Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PLC Systems -- Ignore unavailable to you. Want to Upgrade?

To: Rob C. who wrote (1140)	9/28/1999 9:18:00 AM
From: Rob C.	Respond to of 1202

News today... New Directors Provide Significant Medical and Financial Industry Expertise FRANKLIN, Mass., Sept. 28 /PRNewswire/ -- PLC Systems Inc. (Amex: PLC), today announced that Alan Magazine and Kevin Dunn have been appointed to the Company's Board of Directors, effective immediately. PLC Systems' Chairman, President and CEO Ed Pendergast stated, "We are delighted to add experienced, talented executives to the board. The addition of Kevin and Alan enhances the breadth and depth of the Company's board of directors. Both directors will be important resources as PLC continues to focus on expanding the Company's market share in the growing TMR market." For the past 10 years, Magazine has served as President and Chief Executive Officer of the Health Industry Manufacturers Association (HIMA). HIMA is the largest, worldwide association for medical technology companies. The association represents more than 800 companies. Prior to HIMA, Magazine was the President and Chief Executive Officer of the Foundation for American Economic Competitiveness and its operating arm, the Council on Competitiveness. Dunn is the senior managing director for the Boston office of The Robinson Humphrey Company, an investment banking firm. Previously, Dunn had worked for more than 15 years for Tucker Anthony Incorporated, most recently as senior managing director for the investment banking group and a director of the firm. Working with leading researchers and premier heart surgery centers around the world, PLC Systems Inc. developed the world's first FDA-approved TMR device, a high-powered laser known as The Heart Laser System. Designed to perform TMR in the safest manner possible, The Heart Laser System was approved by the U.S. Food and Drug Administration in August 1998 for treatment of the estimated 80,000 domestic patients each year who suffer from severe coronary artery disease but cannot be treated with conventional coronary revascularization techniques such as bypass surgery or angioplasty. Note: Certain of the above statements are forward-looking statements that involve risks and uncertainties. Actual results could differ materially from those indicated by such forward-looking statements as a result of a variety of factors, including operational changes, competitive developments, regulatory approval requirements, the ability to convince health care professionals and third party payers of the medical and economic benefits of The Heart Laser System, no assurance that all payers will reimburse health care providers who perform TMR procedures or that reimbursement, if provided, will be adequate, and risk factors described in the Company's annual report, SEC form 10-K for fiscal year ended December 31, 1998, and the Company's other SEC reports. SOURCE PLC Systems Inc. -0- 09/28/1999 /CONTACT: John Jordan, Manager of Investor Relations of PLC Systems Inc., 508-541-8800, ext. 145/ /Web site: plcmed.com (PLC) CO: PLC Systems Inc. ST: Massachusetts IN: MTC SU: PER KD -- NETU029 -- 4528 09/28/1999 08:33 EDT prnewswire.com //Begin Meta Data// Selector Code: ..l.q Copyright 1999, PR Newswire

To: Rob C. who wrote (1140)	9/28/1999 12:45:00 PM
From: tuck	Read Replies (1) \| Respond to of 1202

Rob, I am keeping my eye on PLC. It should report in a about a month. I'd like to know whose procedure was being used in this study, too. One has to be a full Lancet subscriber to get the full Lancet article. The abstract mentions only TMR, not which TMR. Perhaps the affiliations of the investigators could be found out. I believe there are lists of hospitals where the machines are available on the website. I think ESTI likely has such a list available, too. Look at abstract for institutions attached to names of authors. Match to institution with machines. Since there are really only two players in the industry, this shouldn't be too hard. I'm busy now, but I'll have a look tomorrow. Cheers, Tuck